| ID | 10049 |
| Vaccine Name | CoronaVac |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Sinovac Biotech Ltd. |
| Year of Manufacturing | NA |
| Manufacturing Country | China |
| Age | 18 years and above |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | Aluminum (aluminium hydroxide) |
| Target Strain | Inactivated SARS-CoV-2 virus |
| Description | Vero cells |
| Approving Organisation | NMPA, WHO |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | Inactivated SARS-CoV-2 Vaccine (Vero Cell) (lnCoV),CoronaVac |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT05107557
|